BioCentury
ARTICLE | Financial News

Alexion announces $400M share repurchase program

November 9, 2012 1:41 AM UTC

Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) said its board authorized the repurchase of up $400 million of the company's stock. At Sept. 30, Alexion had $905.5 million in cash and a nine-month operatin...